3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
7
CNS
2
Other solid neoplasm
1
Myeloid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
11
Carcinoma, Renal Cell
10
Breast Neoplasms
6
Urinary Bladder Neoplasms
5
Melanoma
4
Neoplasm Metastasis
3
Lymphoma
3
Lung Neoplasms
3
Kidney Neoplasms
3
Wilms Tumor
2
Thyroid Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Liver Neoplasms
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Astrocytoma
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Filgrastim
6
Cyclophosphamide
6
Carboplatin
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Ifosfamide
5
Temozolomide
4
Nuclear Medicine Department, Hospital
4
Gemcitabine
4
Etoposide
4
Granulocyte Colony-Stimulating Factor
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ixabepilone
2
ivosidenib
2
etoposide phosphate
2
ensartinib
2
cabozantinib
2
belinostat
2
Vincristine
2
Vemurafenib
2
Topotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Sirolimus
×
Genitourinary
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled